The Board of Directors of Dr. Lal Path Labs Ltd. met on April 25, 2025, and approved the Audited Standalone & Consolidated Financial Results for the quarter and financial year ended March 31, 2025.
Consolidated Financial Highlights:
Revenue from Operations for Q4 FY25 stood at ₹602.6 crore, compared to ₹545.4 crore in Q4 FY24.
Total Income for Q4 FY25 was ₹628.4 crore, up from ₹563.8 crore in Q4 FY24.
Profit After Tax for Q4 FY25 was ₹155.5 crore, significantly higher than ₹85.8 crore in Q4 FY24.
For the full financial year FY25, Revenue from Operations was ₹2,461.4 crore, compared to ₹2,226.6 crore in FY24.
Total Income for FY25 was ₹2,554.8 crore, against ₹2,295.8 crore in FY24.
Profit After Tax for FY25 reached ₹492.2 crore, versus ₹362.3 crore in FY24.
Consolidated Basic Earnings Per Share (EPS) for FY25 was ₹58.48, compared to ₹43.05 in FY24.
The Board recommended a final dividend of ₹6 per equity share (@ 60% on a face value of ₹10 each) for the financial year ended March 31, 2025, subject to approval at the ensuing Annual General Meeting (AGM).
The record date for the purpose of payment of the final dividend is fixed as June 06, 2025.
The final dividend will be dispatched/credited within 30 days of approval by the members at the AGM.
The total dividend for FY25 (including interim dividends already paid) is ₹24 per share.
Approved the re-appointment of Mr. Rohit Bhasin as a Non-Executive Independent Director for five consecutive years commencing from November 08, 2025, subject to AGM approval.
Approved the re-appointment of Mr. Arun Duggal as a Non-Executive Independent Director for three consecutive years commencing from February 02, 2026, subject to AGM approval.
Approved the re-appointment of M/s Ernst & Young LLP as the Internal Auditors and M/s A.G. Agarwal & Associates as the Cost Auditors for FY 2025-26.
Approved the appointment of M/s Chandrasekaran Associates as the Secretarial Auditors for a term of five consecutive financial years from FY 2025-26 to FY 2029-30, subject to AGM approval.
Decided to convene the 31st Annual General Meeting (AGM) on Saturday, June 28, 2025, through Video Conferencing/Other Audio-Visual Means (VC/OAVM).